Fas promoter polymorphisms: Genetic predisposition to sarcoidosis in African-Americans

Tissue Antigens

Volumn 72, Issue 1, 2008, Pages 39-48

  Wasfi, Y S ^a   Silveira, L J ^b   Jonth, A ^b   Hokanson, J E ^c   Fingerlin, T ^c   Sato, H ^d   Parsons, C E ^b   Lympany, P ^d   Welsh, K ^d   Du Bois, R M ^b   Newman, L S ^c   Maier, L A ^b,c  

^a MERCK RESEARCH LABORATORIES   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

African American race; Apoptosis; DNA; Fas; Genetic polymorphism; Sarcoidosis; Sequence analysis

Indexed keywords

FAS ANTIGEN;

ADULT; AFRICAN AMERICAN; AGED; ALLELE; APOPTOSIS; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DNA SEQUENCE; EUROPEAN AMERICAN; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INFLAMMATION; LOGISTIC REGRESSION ANALYSIS; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RISK FACTOR; SARCOIDOSIS; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; ANTIGENS, CD95; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); SARCOIDOSIS; SEVERITY OF ILLNESS INDEX;

EID: 45249114402     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2008.01060.x     Document Type: Article

References (29)

1. Kunitake R, Kuwano K, Miyazaki H et al. Apoptosis in the course of granulomatous inflammation in pulmonary sarcoidosis. Eur Respir J 1999 : 13 : 1329 37.
2. Agostini C, Zambello R, Sancetta R et al. Expression of tumor necrosis factor-receptor superfamily members by lung T lymphocytes in interstitial lung disease. Am J Respir Crit Care Med 1996 : 153 : 1359 67.
3. Dai H, Guzman J, Costabel U. Increased expression of apoptosis signalling receptors by alveolar macrophages in sarcoidosis. Eur Respir J 1999 : 13 : 1451 4.
4. Domagala-Kulawik J, Droszcz P, Kraszewska I, Chazan R. Expression of Fas antigen in the cells from bronchoalveolar lavage fluid (BALF). Folia Histochem Cytobiol 2000 : 38 : 185 8.
5. Kittle LA, Sawyer RT, Fadok VA, Maier LA, Newman LS. Beryllium induces apoptosis in human lung macrophages. Sarcoidosis Vasc Diffuse Lung Dis 2002 : 19 : 101 13.
6. Sawyer RT, Fadok VA, Kittle LA, Maier LA, Newman LS. Beryllium-stimulated apoptosis in macrophage cell lines. Toxicology 2000 : 149 : 129 42.
7. Sawyer RT, Kittle LA, Hamada H, Newman LS, Campbell PA. Beryllium-stimulated production of tumor necrosis factor-alpha by a mouse hybrid macrophage cell line. Toxicology 2000 : 143 : 235 47.
8. Huang QR, Morris D, Manolios N. Identification and characterization of polymorphisms in the promoter region of the human Apo-1/Fas (CD95) gene. Mol Immunol 1997 : 34 : 577 82.
9. Nolsoe RL, Kristiansen OP, Sangthongpitag K et al. Complete molecular scanning of the human Fas gene: mutational analysis and linkage studies in families with type I diabetes mellitus. The Danish Study Group of Diabetes in Childhood and The Danish IDDM Epidemiology and Genetics Group. Diabetologia 2000 : 43 : 800 8.
10. Huang QR, Manolios N. Investigation of the -1377 polymorphism on the Apo-1/Fas promoter in systemic lupus erythematosus patients using allele-specific amplification. Pathology 2000 : 32 : 126 30.
11. Kanemitsu S, Ihara K, Saifddin A et al. A functional polymorphism in fas (CD95/APO-1) gene promoter associated with systemic lupus erythematosus. J Rheumatol 2002 : 29 : 1183 8.
12. Nolsoe RL, Kelly JA, Pociot F et al. Functional promoter haplotypes of the human FAS gene are associated with the phenotype of SLE characterized by thrombocytopenia. Genes Immun 2005 : 6 : 699 706.
13. Berlin M, Fogdell-Hahn A, Olerup O, Eklund A, Grunewald J. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 1997 : 156 : 1601 5.
14. Rybicki BA, Iannuzzi MC, Frederick MM et al. Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med 2001 : 164 : 2085 91.
15. Sato H, Grutters JC, Pantelidis P et al. HLA-DQB1*0201: a marker for good prognosis in British and Dutch patients with sarcoidosis. Am J Respir Cell Mol Biol 2002 : 27 : 406 12.
16. Rybicki BA, Maliarik MJ, Major M, Popovich J Jr., Iannuzzi MC. Genetics of sarcoidosis. Clin Chest Med 1997 : 18 : 707 17.
17. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS) the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999 : 160 : 736 55.
18. ACCESS Research Group. Design of a case control etiologic study of sarcoidosis (ACCESS). J Clin Epidemiol 1999 : 52 : 1173 86.
19. Judson M, Baughman R, Teirstein A et al. Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. Sarcoidosis Vasc Diffuse Lung Dis 1999 : 16 : 75 86.
20. Baughman RP, Teirstein AS, Judson MA et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001 : 164 : 1885 9.
21. Welsh K, Bunce M. Molecular typing for the MHC with PCR-SSP [Review]. Rev Immunogenet 1999 : 1 : 157 76.
22. Rowland C. Haplo.score. R version translation by Gregory R. Warnes ed. Mayo Foundation for Medical Education and Research, 2001. Rochester, Minnesota.
23. van Veen T, Kalkers NF, Crusius JB et al. The FAS-670 polymorphism influences susceptibility to multiple sclerosis. J Neuroimmunol 2002 : 128 : 95 100.
24. Rossman MD, Thompson B, Frederick M et al. HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. Am J Hum Genet 2003 : 73 : 720 35.
25. Iannuzzi MC, Iyengar SK, Gray-McGuire C et al. Genome-wide search for sarcoidosis susceptibility genes in African Americans. Genes Immun 2005 : 6 : 509 18.
26. Schurmann M, Reichel P, Muller-Myhsok B et al. Results from a genome-wide search for predisposing genes in sarcoidosis. Am J Respir Crit Care Med 2001 : 164 : 840 6.
27. Spagnolo P, Renzoni EA, Wells AU et al. C-C chemokine receptor 5 gene variants in relation to lung disease in sarcoidosis. Am J Respir Crit Care Med 2005 : 172 : 721 8.
28. Spagnolo P, Renzoni EA, Wells AU et al. C-C chemokine receptor 2 and sarcoidosis: association with Lofgren's syndrome. Am J Respir Crit Care Med 2003 : 168 : 1162 6.
29. Mahfoudh W, Bel Hadj Jrad B, Romdhane A, Chouchane L. A polymorphism in FAS gene promoter correlated with circulating soluble FAS levels. Int J Immunogenet 2007 : 34 : 209 12.